Filter News
Area of Research
- (-) Advanced Manufacturing (2)
- (-) Neutron Science (21)
- Biology and Environment (5)
- Clean Energy (15)
- Climate and Environmental Systems (1)
- Fusion and Fission (1)
- Fusion Energy (1)
- Isotopes (1)
- Materials (15)
- Materials for Computing (1)
- National Security (2)
- Nuclear Science and Technology (5)
- Supercomputing (13)
News Topics
- (-) Artificial Intelligence (1)
- (-) Climate Change (1)
- (-) Nanotechnology (4)
- (-) Neutron Science (21)
- (-) Nuclear Energy (1)
- 3-D Printing/Advanced Manufacturing (6)
- Bioenergy (3)
- Biomedical (3)
- Computer Science (5)
- Coronavirus (3)
- Cybersecurity (1)
- Environment (2)
- Machine Learning (1)
- Materials Science (6)
- Microscopy (1)
- National Security (1)
- Physics (4)
- Quantum Science (2)
- Summit (4)
- Sustainable Energy (2)
- Transformational Challenge Reactor (1)
- Transportation (2)
Media Contacts
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
After more than a year of operation at the Department of Energy’s (DOE’s) Oak Ridge National Laboratory (ORNL), the COHERENT experiment, using the world’s smallest neutrino detector, has found a big fingerprint of the elusive, electrically neutral particles that interact only weakly with matter.
Researchers used neutrons to probe a running engine at ORNL’s Spallation Neutron Source